Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 6.3% in the morning session after Citigroup downgraded the stock to Neutral from Buy. The analyst firm adjusted its rating on the life science ...

Rising retail participation incentivizes data-driven, “elite” traders to use “information asymmetry” and spreads caused by casual investors seeking a quick buck, 10x said. Prediction markets are ...